Active, not recruitingPhase 1NCT07204977

Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS)

Studying Amyotrophic lateral sclerosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Principal Investigator
Justin Y Kwan, M.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Intervention
Acamprosate calcium(drug)
Enrollment
30 enrolled
Eligibility
18-99 years · All sexes
Timeline
2026 – 2028

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07204977 on ClinicalTrials.gov

Other trials for Amyotrophic lateral sclerosis

Additional recruiting or active studies for the same condition.

See all trials for Amyotrophic lateral sclerosis →

← Back to all trials